Open access
Open access
Powered by Google Translator Translator

GI Surgery – Liver

M-A | Percutaneous catheter drainage superior to needle aspiration for liver abscess treatment success

9 Aug, 2023 | 15:12h | UTC

Percutaneous catheter drainage versus percutaneous needle aspiration for liver abscess: a systematic review, meta-analysis and trial sequential analysis – BMJ Open

 


Nonrandomized Controlled Trial | Long-term survival of 80% in selected colorectal cancer patients post liver transplant

1 Aug, 2023 | 14:20h | UTC

Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial – JAMA Surgery (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Fluorescence-guided surgery: comprehensive review

18 May, 2023 | 13:34h | UTC

Fluorescence-guided surgery: comprehensive review – BJS Open

 

Commentary on Twitter

 


EASL-ILCA Clinical practice guidelines on the management of intrahepatic cholangiocarcinoma

9 May, 2023 | 14:47h | UTC

EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma – Journal of Hepatology

 

Commentary on Twitter

 


Review | Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma

28 Apr, 2023 | 13:03h | UTC

Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma – CA: A Cancer Journal for Clinicians

 


Perspective | Liver transplantation for patients with severe acute on chronic liver failure: it is time to change paradigms

25 Apr, 2023 | 14:37h | UTC

Liver transplantation for patients with severe acute on chronic liver failure: it is time to change paradigms – Intensive Care Medicine

 

Commentary on Twitter

 


Overcoming size disparity in liver transplant access: prioritizing smaller donors for smaller candidates

3 Apr, 2023 | 13:41h | UTC

Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies – JAMA Surgery (free for a limited period)

Invited Commentary: Addressing Size-Based Disparities in Liver Transplant – JAMA Surgery (free for a limited period)

 

Commentary on Twitter

 


Review | Platelet aggregation inhibitors and anticoagulants in gastroenterological and visceral surgical procedures

1 Mar, 2023 | 14:03h | UTC

Platelet Aggregation Inhibitors and Anticoagulants in Gastroenterological and Visceral Surgical Procedures – Deutsches Ärzteblatt international

Related: Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)

 


Post-transplant biliary complications: advances in pathophysiology, diagnosis, and treatment

3 Feb, 2023 | 14:01h | UTC

Post-transplant biliary complications: advances in pathophysiology, diagnosis, and treatment – BMJ Open Gastroenterology

 


M-A | Major complications and mortality after resection of intrahepatic cholangiocarcinoma

3 Feb, 2023 | 13:43h | UTC

Major complications and mortality after resection of intrahepatic cholangiocarcinoma: A systematic review and meta-analysis – Surgery

 


M-A | Impact of perioperative steroid administration in patients undergoing elective liver resection

19 Jan, 2023 | 14:00h | UTC

Impact of perioperative steroid administration in patients undergoing elective liver resection: meta-analysis – BJS Open

 


ERAS Guidelines for perioperative care for liver surgery.

1 Nov, 2022 | 12:16h | UTC

Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022 – World Journal of Surgery

Related:

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

 


Systematic Review | Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

5 Sep, 2022 | 14:13h | UTC

Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease – Cochrane Library

Summary: How accurate are contrast-enhanced ultrasound scans for detecting hepatocellular carcinoma? – Cochrane Library

 


Meta-analysis of observational studies | In patients with hepatocellular carcinoma, intraoperative blood salvage during liver transplantation appears safe.

30 Aug, 2022 | 12:03h | UTC

Safety of Intraoperative Blood Salvage During Liver Transplantation in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-analysis – Annals of Surgery

 


Review | New concepts in the treatment of hepatocellular carcinoma.

24 Aug, 2022 | 13:56h | UTC

New concepts in the treatment of hepatocellular carcinoma – UEG Journal

 


Review | Acute liver failure management and liver transplantation.

15 Aug, 2022 | 11:41h | UTC

CAQ Corner: Acute liver failure management and liver transplantation – Liver Transplantation

 


RCT | Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma.

5 Aug, 2022 | 13:50h | UTC

Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Adding TACE to Lenvatinib Boosts Survival in Advanced Liver Cancer — In China-based trial, overall survival in first-line improved by 6 months versus lenvatinib alone – MedPage Today (free registration required)

 


Case-Control Study | Survival benefit of living-donor liver transplant.

4 Aug, 2022 | 13:59h | UTC

Survival Benefit of Living-Donor Liver Transplant – JAMA Surgery

Commentaries:

Just How Low a Model for End-stage Liver Disease Score Benefits From Living-Donor Liver Transplant? – JAMA Surgery (free for a limited period)

Low MELD Score No Barrier to Long Survival After Living-Donor Transplant — End-stage liver disease patients with scores as low as 11 achieved survival of 13 years or beyond – MedPage Today (free registration required)

 


M-A | Repeat hepatic resection vs. percutaneous ablation for the treatment of recurrent hepatocellular carcinoma.

4 Aug, 2022 | 13:27h | UTC

Repeat hepatic resection versus percutaneous ablation for the treatment of recurrent hepatocellular carcinoma: meta-analysis – BJS Open

 

Commentary on Twitter

 


M-A | Evidence on indications and techniques to increase the future liver remnant in children undergoing extended hepatectomy.

22 Jul, 2022 | 11:33h | UTC

Evidence on Indications and Techniques to Increase the Future Liver Remnant in Children Undergoing Extended Hepatectomy: A Systematic Review and Meta-Analysis of Individual Patient Data – Frontiers in Pediatrics

 


Review | Liver biopsy in patients with alcohol-associated liver disease with acute-on-chronic liver failure.

22 Jul, 2022 | 11:28h | UTC

Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure – Journal of Clinical and Experimental Hepatology

 


Cystic liver lesions: a pictorial review.

18 Jul, 2022 | 10:48h | UTC

Cystic liver lesions: a pictorial review – Insights into Imaging

 


Hypertensive disorders in pregnancy complicated by liver rupture or hematoma: a systematic review of 391 reported cases.

12 Jul, 2022 | 11:48h | UTC

Hypertensive disorders in pregnancy complicated by liver rupture or hematoma: a systematic review of 391 reported cases – World Journal of Emergency Surgery

 


Review: Portal vein thrombosis in cirrhosis.

15 Jun, 2022 | 10:38h | UTC

Portal Vein Thrombosis in Cirrhosis – Journal of Clinical and Experimental Hepatology

 


Causes of liver cancer are changing around the world: some up, some down.

13 Jun, 2022 | 07:54h | UTC

News Release: Causes of Liver Cancer are Changing Around the World: Some Up, Some Down – UC San Diego Health

Original Study: Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer – Cell Metabolism (link to abstract – $ for full-text)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.